LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 10 Apr 2026
MHRA approval

olezarsen (Tryngolza)

Published on 10 Apr 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome
MHRA announcement ↗ All events: olezarsen (Tryngolza)

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.